Autoimmune Progesterone Dermatitis: 4 Treatment Options

Autoimmune progesterone dermatitis (APD) is a rare condition characterised by recurrent skin eruptions triggered by endogenous progesterone during the luteal phase of the menstrual cycle. Symptoms typically emerge 3–10 days prior to menses when progesterone levels peak, resolving shortly after menstruation begins. This hypersensitivity reaction may mimic various dermatoses but is distinguished by its strict cyclical timing.

What is autoimmune progesterone dermatitis?

**Autoimmune progesterone dermatitis** refers to a hypersensitivity reaction to one’s own progesterone, manifesting as cyclical dermatological symptoms aligned with the menstrual cycle’s luteal phase. First described in 1964, APD affects women of reproductive age and can significantly impair quality of life due to predictable premenstrual flares. The term “autoimmune” reflects the immune-mediated response to an endogenous hormone, though mechanisms blend allergic and autoimmune features, often involving mast cell degranulation and histamine release.

Unlike typical dermatitis, APD’s hallmark is its temporality: rashes appear reliably 3–4 days before menstruation (or up to 10 days in some cases), correlating precisely with progesterone surges post-ovulation. Progesterone levels rise 10–35 times higher in the luteal phase, potentially overwhelming sensitised immune systems. Pregnancy or exogenous progestins (e.g., contraceptives) can exacerbate or trigger symptoms by elevating progesterone thousands-fold.

Who gets autoimmune progesterone dermatitis?

APD predominantly affects women aged 20–45 in their reproductive years, with fewer than 100 cases documented worldwide, underscoring its rarity. No strong ethnic or genetic predispositions are established, though prior exposure to synthetic progestogens (e.g., oral contraceptives, progesterone-only pills, or fertility treatments) is reported in up to 70% of cases. Endogenous-onset APD occurs without such history, suggesting spontaneous sensitisation.

Risk factors include:

• Prior use of progesterone-containing contraceptives or hormone therapies
• Conditions elevating progesterone, such as pregnancy or in vitro fertilisation (IVF)
• Possible cross-reactivity with hydrocortisone or 17-α-hydroxyprogesterone
• Underlying mast cell disorders or histamine intolerance

APD may impact fertility due to flares during conception attempts or early pregnancy.

Causes of autoimmune progesterone dermatitis

The precise aetiology remains elusive, but hypersensitivity to progesterone—endogenous or synthetic—is central. Hypotheses include:

• Exogenous sensitisation: Synthetic progestins in oral contraceptives (OCPs) or injectables may act as haptens, prompting IgE-mediated responses via antigen-presenting cells and TH2 lymphocytes.
• Endogenous autoimmunity: Spontaneous antibody or T-cell recognition of native progesterone, possibly triggered by molecular mimicry or hormonal fluctuations.
• Mast cell mediation: Progesterone directly degranulates mast cells, releasing histamine and causing urticaria, angioedema, and pruritus independent of IgE.
• Cross-reactivity: Structural similarity between progesterone and corticosteroids like hydrocortisone.

Not all progesterone-exposed women develop APD, implying individual immune susceptibility.

Clinical features of autoimmune progesterone dermatitis

APD presents with polymorphic rashes 3–10 days pre-menses, resolving post-menses, recurring cyclically. Severity varies from mild pruritus to anaphylaxis.

Skin lesions

Most common morphologies include:

• Urticaria/hives: Transient, itchy wheals on trunk/limbs (60–70% of cases)
• Eczematous eruptions: Dry, inflamed patches with lichenification
• Angioedema: Deep swelling of face, lips, or genitalia

Less common:

• Erythema multiforme (target lesions)
• Papulovesicular or pustular rashes
• Fixed drug eruptions
• Vulvovaginal candidiasis or pruritus
• Oral mucosa involvement

Systemic symptoms

• Pruritus (universal)
• Asthma-like dyspnea
• Anaphylaxis (rare)

Symptoms spare anogenital areas in some but affect them in others. Flares worsen with pregnancy or progestin exposure.

Diagnosis of autoimmune progesterone dermatitis

Diagnosis is clinical, relying on:

• Cyclical history: Rash onset 3–10 days pre-menses, resolution within 1–2 days post-menses
• Exclusion: Rule out cyclic exacerbations of lupus, acne, psoriasis, or premenstrual dysphoric disorder (PMDD)

Investigations:

• Skin biopsy: Non-specific (perivascular infiltrate, eosinophils)
• Intradermal progesterone challenge: Local/systemic reaction (not standardised)
• In vitro tests: Progesterone-specific IgE or basophil activation (research only)
• Hormone levels/timing: Confirm luteal phase correlation

Differential includes PMDD (mood-focused, no hives), lupus (photosensitive, multi-organ), and contact dermatitis.

Treatment of autoimmune progesterone dermatitis

Treatment escalates from symptomatic to definitive based on severity and fertility desires.

Symptomatic

• Antihistamines: Non-sedating H1-blockers (cetirizine 10–20mg daily) ± H2-blockers (ranitidine)
• Topicals: Potent steroids (clobetasol) for eczema; calcineurin inhibitors
• Short-course oral steroids: Prednisone 0.5mg/kg for flares
• Mast cell stabilisers: Cromolyn sodium

Hormonal suppression

Desensitisation

Subcutaneous progesterone injections escalating from 5–100mg over months induce tolerance in 50–70%.

Definitive

• Total abdominal hysterectomy + bilateral salpingo-oophorectomy (TAH-BSO): Curative in refractory cases post-childbearing

Lifestyle: Low-histamine diet, stress reduction.

Outcomes and fertility in autoimmune progesterone dermatitis

With treatment, 80% achieve control; untreated cases disrupt life profoundly. Pregnancy often triggers severe flares, but IVF with GnRH suppression succeeds. Post-menopause, symptoms remit.

Frequently Asked Questions

Is autoimmune progesterone dermatitis curable?

No universal cure exists, but symptoms are manageable in most; hysterectomy offers definitive relief post-childbearing.

How is APD diagnosed?

Primarily by cyclical history; confirmed via progesterone challenge tests.

Can birth control help APD?

Often worsens due to synthetic progestins; GnRH agonists preferred.

Does APD affect pregnancy?

Yes, exacerbates severely; requires specialised management.

Is APD the same as PMDD?

No—PMDD is neuropsychiatric; APD is dermatological/hypersensitivity.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

Sneha TeteBeauty & Lifestyle Writer

 

Sneha is a relationships and lifestyle writer with a strong foundation in applied linguistics and certified training in relationship coaching. She brings over five years of writing experience to renewcure,  crafting thoughtful, research-driven content that empowers readers to build healthier relationships, boost emotional well-being, and embrace holistic living.

Read full bio of Sneha Tete